Cystatin C is associated with adverse COVID-19 outcomes in diverse populations. (2022)

First Author: Kleeman SO

Attributed to: Quantitative Traits in Health and Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2022.105040

PubMed Identifier: 36062073

Publication URI: http://europepmc.org/abstract/MED/36062073

Type: Journal Article/Review

Volume: 25

Parent Publication: iScience

Issue: 10

ISSN: 2589-0042